SpA test kit AESKULISA®

IgAserumtissue

Connective tissue diseases are systemic autoimmune diseases including SLE, scleroderma, polymyositis/dermatomyositis, mixed connective tissue diseases (MCTD) and Sjögren’s syndrome. In Rheumatoid arthritis (RA) mainly the joints and associated structures are affected. Early diagnosis and prognosis of RA are essential to prevent irreversible joint destruction. AESKU® Rheumatology line offers a complete panel of routine and research usage kits, including more than 40 different parameters. Intended Use: AESKULISA® SpA detect is a solid phase enzyme immunoassay with recombinant human CD74 for the semi-quantitative determination of IgA antibodies against human CD74 in the serum. The test is used for diagnosing SpA (spondyloarthritis) and accordingly for clarifying the origin of inflammatory or chronic back pain. It is not a screening assay and is not used for the differential diagnosis of rheumatoid arthritis and systemic lupus erythematosus (SLE). Recombinant Antigens: Recombinant human CD74 Native Antigens: n.a. Description: - SpA Detect Kit Configuration: - Single - A Cut Off: - 15 Range: - 0 - 300 U/ml Standard: - -